Characteristic |
N |
Fine & Gray model Univariate anemia_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.48 |
1.07, 2.04 |
0.019 |
Age |
434 |
1.01 |
1.00, 1.02 |
0.140 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.91 |
0.69, 1.20 |
0.490 |
baseline_cre_egfr |
434 |
0.99 |
0.98, 1.00 |
0.007 |
Characteristic |
N |
Fine & Gray Model Multivariate anemia_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.42 |
1.01, 1.99 |
0.043 |
Age |
434 |
1.00 |
0.98, 1.01 |
0.710 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.91 |
0.68, 1.20 |
0.500 |
baseline_cre_egfr |
434 |
0.99 |
0.98, 1.00 |
0.021 |
Characteristic |
N |
Fine & Gray model Univariate anemia_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.89 |
1.14, 3.13 |
0.014 |
Age |
434 |
1.01 |
0.99, 1.03 |
0.250 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.00 |
0.62, 1.62 |
>0.999 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.080 |
Characteristic |
N |
Fine & Gray Model Multivariate anemia_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.78 |
1.04, 3.03 |
0.035 |
Age |
434 |
1.00 |
0.97, 1.02 |
0.710 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.99 |
0.60, 1.61 |
0.960 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.160 |
Characteristic |
N |
Fine & Gray model Univariate throm_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.46 |
0.83, 2.57 |
0.190 |
Age |
434 |
1.01 |
0.99, 1.03 |
0.210 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.71 |
1.01, 2.89 |
0.044 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.066 |
Characteristic |
N |
Fine & Gray Model Multivariate throm_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.30 |
0.73, 2.32 |
0.380 |
Age |
434 |
1.00 |
0.98, 1.02 |
0.800 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.73 |
1.01, 2.96 |
0.046 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.090 |
Characteristic |
N |
Fine & Gray model Univariate throm_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.61 |
1.13, 6.02 |
0.025 |
Age |
434 |
1.02 |
0.99, 1.05 |
0.230 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
2.14 |
0.90, 5.08 |
0.085 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.02 |
0.540 |
Characteristic |
N |
Fine & Gray Model Multivariate throm_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.36 |
0.96, 5.78 |
0.061 |
Age |
434 |
1.00 |
0.97, 1.04 |
0.860 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
2.03 |
0.83, 4.96 |
0.120 |
baseline_cre_egfr |
434 |
1.00 |
0.97, 1.03 |
0.780 |
Characteristic |
N |
Fine & Gray model Univariate aki_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.77 |
0.94, 3.33 |
0.076 |
Age |
434 |
1.01 |
0.99, 1.03 |
0.480 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.03 |
0.56, 1.90 |
0.930 |
baseline_cre_egfr |
434 |
1.01 |
0.99, 1.03 |
0.260 |
Characteristic |
N |
Fine & Gray Model Multivariate aki_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.78 |
0.91, 3.50 |
0.092 |
Age |
434 |
1.02 |
0.99, 1.05 |
0.180 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.93 |
0.51, 1.70 |
0.810 |
baseline_cre_egfr |
434 |
1.02 |
1.00, 1.05 |
0.096 |
Characteristic |
N |
Fine & Gray model Univariate aki_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.29 |
0.51, 10.2 |
0.280 |
Age |
434 |
1.04 |
0.98, 1.10 |
0.200 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.60 |
0.36, 7.12 |
0.540 |
baseline_cre_egfr |
434 |
1.02 |
0.97, 1.06 |
0.440 |
Characteristic |
N |
Fine & Gray Model Multivariate aki_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.90 |
0.39, 9.40 |
0.430 |
Age |
434 |
1.07 |
0.96, 1.19 |
0.250 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.28 |
0.32, 5.11 |
0.720 |
baseline_cre_egfr |
434 |
1.05 |
0.95, 1.15 |
0.340 |
Death only
Characteristic |
N |
**cox model Univariate death 365
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
5.89 |
3.25, 10.7 |
<0.001 |
Age |
434 |
1.03 |
1.01, 1.06 |
0.019 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.15 |
0.65, 2.05 |
0.635 |
baseline_cre_egfr |
434 |
1.00 |
0.98, 1.01 |
0.759 |
Characteristic |
**cox model multivariate death 365
|
HR |
95% CI |
p-value |
group_2 |
|
|
|
0 |
— |
— |
|
1 |
5.50 |
2.98, 10.1 |
<0.001 |
Age |
1.03 |
1.00, 1.06 |
0.096 |
Sex |
|
|
|
Female |
— |
— |
|
Male |
0.97 |
0.54, 1.75 |
0.927 |
baseline_cre_egfr |
1.01 |
0.99, 1.03 |
0.192 |
Characteristic |
N |
**cox model Univariate death 90
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
12.0 |
3.98, 36.2 |
<0.001 |
Age |
434 |
1.03 |
0.99, 1.07 |
0.203 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.32 |
0.54, 3.26 |
0.543 |
baseline_cre_egfr |
434 |
1.00 |
0.98, 1.03 |
0.786 |
Characteristic |
**cox model multivariate death 90
|
HR |
95% CI |
p-value |
group_2 |
|
|
|
0 |
— |
— |
|
1 |
12.4 |
3.95, 38.8 |
<0.001 |
Age |
1.01 |
0.96, 1.06 |
0.605 |
Sex |
|
|
|
Female |
— |
— |
|
Male |
1.01 |
0.40, 2.51 |
0.986 |
baseline_cre_egfr |
1.02 |
0.99, 1.05 |
0.225 |
KM curves

KM curves
